The role of epicardial adipose tissue (EAT) volume in subclinical left atrial (LA) dysfunction is unclear. Therefore, we aims to evaluate the relationships between EAT volumes, and LA functions and global longitudinal strain assessed in people without obstructive coronary artery disease or atrial fibrillation. We found that BSA-indexed total EAT was closely associated with impaired 2D LA global longitudinal strain, reduced 3D LA ejection fraction and reduced 3D active LA ejection fraction.
Introduction
Epicardial adipose tissue (EAT) is a metabolically active visceral fat depot between the myocardium and visceral pericardium. As EAT is in direct contact with the adjacent myocardium, there are potential physiological (including paracrine) interactions between these two tissues. 1 With its proatherosclerotic effects and tendency to secrete proinflammatory mediators, EAT is associated with the pathogenesis of coronary artery disease (CAD) and the metabolic syndrome. 2 The volume of EAT is a predictor for persistence of arrhythmia. 3 Additionally, EAT volumes could predict atrial fibrillation (AF) recurrence after catheter ablation. 4 This interplay between EAT and AF may involve adipocyte infiltration and atrial fibrosis, resulting in functional remodeling of the atria and arrhythmogenesis.
During the cardiac cycle, the LA serves multiple functions, acting as a reservoir for pulmonary venous return during left ventricular (LV) systole, a conduit for blood flow during early diastole, and an active pump chamber that augments ventricular filling in late diastole. 5 LA functional remodeling is commonly marked by decreased LA function, which can be assessed by 2D and 3D echocardiography. 6, 7 LA 2D longitudinal strain has been reported to correlate strongly with the extent of LA fibrosis and remodeling, while 3D echocardiography offers better evaluation of LA deformation. 8 In the present study, we aimed to evaluate the association between EAT measured by cardiac CT and LA function assessed by 2D and 3D echocardiography in people without obstructive CAD or atrial fibrillation.
Methods

Study population
Study participants were prospectively recruited from a single Australian tertiary hospital and M A N U S C R I P T
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2 those in low to intermediate risk chest pain underwent a cardiac CT examination, with inclusion criteria of sinus rhythm at the time of enrollment. Exclusion criteria included clinical heart failure (NYHA class II or higher or higher symptoms within six months before screening), moderate or severe valvular disease, obstructive coronary artery disease (defined as >50% stenosis on cardiac CT) or previous history of myocardial infarction, pulmonary hypertension, congenital heart disease, cardiac surgery, history of AF and contraindications to cardiac CT examination.
All patients gave written informed consent to the procedure. The study was approved by the ethics committee of the participating institution.
Cardiac CT and EAT quantification
A total of 130 subjects underwent cardiac CT examination (including calcium scoring and CT coronary angiography) with an electrocardiograph-gated, dual-source CT system (Somatom Definition Flash, Siemens Healthcare, Forchheim, Germany). The imaging parameters were as follows: slice collimation 2×128×0.6mm; gantry rotation time 280ms; tube voltage 100 or 120 kV according to participant's body mass index; and effective tube current 80mA/s. A bolus of 75 mL ioversol (Optiray 350; Mallinckrodt Medical, St Louis, MO) was injected and image acquisition was initiated at 60% of the RR interval. Before the scan, β-blockers (25-100 mg metoprolol orally)
were administrated and participants were instructed to hold their breath during the acquisition of images.
All images were processed with an offline with a workstation (SyngoVia, Siemens Healthcare;
MASS V2010-EXP, Leiden University Medical Center, Leiden, The Netherlands). Serial cross-sectional images were generated from raw data to reformat the images to a slice thickness of 0.75 mm. In order to quantify EAT volume, the pericardium was manually traced from the M A N U S C R I P T
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3 pulmonary artery bifurcation to the diaphragm on each cross-sectional image. Within this region, a CT attenuation threshold between -50 and -200 Hounsfield Units was defined as EAT. [9] [10] [11] The EAT surrounding the LA (LA EAT) was quantified by manually tracing from the pulmonary artery to the coronary sinus at atrial end-diastole. In each participant, quantification of the total EAT and LA EAT was verified by two investigators.
Echocardiography
All study subjects underwent a transthoracic echocardiographic examination at rest in the left Images were obtained during breath-hold and the mean 3D frame rate was 34.6 frames per second.
LA size and function assessment
A 3D pyramidal full volume of the LA was obtained from the apical view with breath-holdover four consecutive cardiac cycles. 12 Sector dimensions, depth, and image contrast were optimized to include the whole LV and LA. The calculation of LA volumes was performed 
2D speckle-tracking echocardiography
All 130 subjects were eligible for speckle-tracking echocardiographic analysis. Longitudinal LA strain was performed offline using dedicated software (EchoPac version 113, GE, Vingmed).
Briefly, a line was manually drawn along the LA endocardium at LA minimum volume and the region of interest would be generated to cover the full thickness of the LA wall. The software automatically tracked the contour on subsequent frames and tracking was manually approved. For each 4-, 2-and 3-chamber views, the LA cavity was divided into six segments (the basal, mid and apical parts of two opposing walls) and strain curves were generated for each segment. for the multivariable analysis. In 10 randomly selected subjects, the intra-and interobserver variability for LA volumes and speckle-tracking parameters were assessed. All analyses were performed with IBM SPSS Statistics 24.0 (IBM Corp, Armonk, NY), and a 2-tailed P<0.05 was considered statistically significant.
Results
Baseline characteristics
Demographic characteristics are presented in Supplemental Table S1 . Of the 130 study subjects, 53.1% were male, and the mean age was 53 ± 9 years. Based on the overall median BSA indexed total EAT volume (EATi) of 48. 
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6 Cardiac CT and echocardiography characteristics
As shown in Table 1 (Figure 1 ).
There was no significant difference with respect to MaxLAVi, PaLAVi or MinLAVi between the two groups.
Age and gender were not associated with EATi volume and LA function (Supplemental Table   S2 ). (Table 3 and Table 4 ). The LA conduit function, assessed by 3D passive LAEF, was less significantly associated with total EATi volume ( Table 5 ). Similar to total EATi volume, the absolute EAT Similar associations were demonstrated when the entire analysis was repeated using EAT values not indexed for BSA.
Determinants of LA volume and function
Reproducibility
The intra-and interobserver correlations for LA global longitudinal strain were 0.99 and 0.97, for MinLAVi were 0.98 and 0.95, for MaxLAVi were 0.98 and 0.82 and for PaLAVi were 0.98 and 0.84 respectively. Reproducibility values for EAT volumes were published previously.
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This study evaluated the relationships between total and LA EAT volume and LA function in subjects without obstructive CAD. We found that total EATi volume was inversely associated with impaired LA longitudinal strain, LAEF and active LAEF, independent of potential confounders.
The association between EAT volume and impaired LA function
2D speckle tracking strain imaging is an evolving technique for the evaluation of myocardial deformation and has been used widely for the assessment of LA function. 15 Compared with volumetric measurements, LA myocardial analysis using 2D speckle tracking echocardiography may detect an early alteration of LA function. 13, 16 It has been shown that global peak atrial longitudinal strain is a strong and independent predictor of LA fibrosis. 17 Additionally, LA strain, evaluated by cardiac magnetic resonance image, was shown a strong degree correlation with fibrofatty replacement at a histological level. 18 In our present study, larger EATi volume was closely associated with more impaired LA global longitudinal strain, regardless of confounding factors. EATi volume negatively correlated with 3D-LAEF and 3D-active LAEF. Gianluca et al.
showed that increased EAT thickness was significantly correlated with atrial enlargement and impairment in diastolic filling in morbidly obese subjects, 19 induce the expression of TGF-β1 and -β2 in the atria, contributing to fibrosis of the atrial myocardium. 21 Additionally, fatty infiltration of the myocardium is another potential mechanism underlying the relationship between EAT and AF. 22, 26 Loss of myocardial continuity would lead to the formation of local arrhythmogenic substrate. It has been reported that EAT contains abundant stem cells. 27, 28 These stem cells could potentially differentiate into myofibroblasts, produce abundant extracellular matrix and take part in the pathological mechanisms of atrial remodeling.
EAT and atrial fibrillation
EAT is likely to play a pathophysiological role in the development of AF. 29 The association between EAT and AF has been described in many experimental and clinical studies.
30-32
Thanassoulis and coworkers conducted analysis based on the Framingham Heart Study Offspring
and Third Generation Cohorts and demonstrated the association between pericardial fat (adipose fat within the pericardial sac) and AF independent of other measures, even after adjustment for M A N U S C R I P T
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established AF risk factors. 33 Gaeta et al. performed a meta-analysis of observational case series studies. 34 After summarizing seven studies, [35] [36] [37] [38] [39] [40] [41] M A N U S C R I P T 
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